• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epidemiologic evaluation of screening for risk factors: application to genetic screening.危险因素筛查的流行病学评估:在基因筛查中的应用
Am J Public Health. 1985 Oct;75(10):1204-8. doi: 10.2105/ajph.75.10.1204.
2
Epidemiological approach to the evaluation of genetic screening in the workplace.工作场所基因筛查评估的流行病学方法。
J Occup Med. 1986 Oct;28(10):1108-11. doi: 10.1097/00043764-198610000-00036.
3
[Predictive genetic screening for type-1 diabetes in the Hungarian population].[匈牙利人群中1型糖尿病的预测性基因筛查]
Orv Hetil. 2004 Feb 15;145(7):337-42.
4
Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors.利用遗传学提高疾病风险因素预测价值的流行病学评估。
Am J Hum Genet. 1995 Apr;56(4):835-44.
5
Screening for Sex Chromosome Aneuploidy by Cell-Free DNA Testing: Patient Choice and Performance.通过游离DNA检测筛查性染色体非整倍体:患者选择与性能表现
Fetal Diagn Ther. 2018;44(2):98-104. doi: 10.1159/000479507. Epub 2017 Aug 23.
6
Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.波兰新生儿筛查中囊性纤维化的诊断——15年经验
Dev Period Med. 2015 Jan-Mar;19(1):16-24.
7
Ethical issues in genetic screening for susceptibility to chronic lung disease.慢性肺病易感性基因筛查中的伦理问题。
J Occup Med. 1988 Jun;30(6):493-501.
8
["Screening" in special situations. Assessing predictive genetic screening for hereditary breast and colorectal cancer].特殊情况下的“筛查”。评估遗传性乳腺癌和结直肠癌的预测性基因筛查
Z Arztl Fortbild Qualitatssich. 2003 Feb;97(1):67-71.
9
Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome.基于单核苷酸多态性的22q11.2缺失综合征无创产前筛查的临床经验。
Ultrasound Obstet Gynecol. 2016 Feb;47(2):177-83. doi: 10.1002/uog.15754. Epub 2016 Jan 5.
10
[A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition].[一种用于诊断BRCA1/2相关乳腺癌-卵巢癌易感性的新评分系统]
Bull Cancer. 2011 Jul;98(7):779-95. doi: 10.1684/bdc.2011.1397.

引用本文的文献

1
Multilevel modelling for measuring interaction of effects between multiple categorical variables: An illustrative application using risk factors for preeclampsia.多水平模型用于测量多个分类变量之间的效应相互作用:使用子痫前期危险因素的说明性应用。
Paediatr Perinat Epidemiol. 2023 Feb;37(2):154-164. doi: 10.1111/ppe.12932. Epub 2022 Nov 10.
2
Cross-classified Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA) to evaluate hospital performance: the case of hospital differences in patient survival after acute myocardial infarction.交叉分类多水平分析个体异质性和判别准确性(MAIHDA)评估医院绩效:以急性心肌梗死后患者生存率的医院差异为例。
BMJ Open. 2020 Oct 23;10(10):e036130. doi: 10.1136/bmjopen-2019-036130.
3
The tyranny of the averages and the indiscriminate use of risk factors in public health: The case of coronary heart disease.公共卫生领域中平均值的暴政以及风险因素的滥用:以冠心病为例。
SSM Popul Health. 2017 Aug 18;3:684-698. doi: 10.1016/j.ssmph.2017.08.005. eCollection 2017 Dec.
4
Association of education & lifestyle factors with the perception of genetic knowledge on the development of lung cancer.教育和生活方式因素与对肺癌发生的遗传知识认知之间的关联。
Indian J Med Res. 2016 May;143(Supplement):S32-S37. doi: 10.4103/0971-5916.191751.
5
Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies.药物遗传学检测评估:在关联研究中呈现临床有效性和潜在人群影响的指标
Pharmacogenomics J. 2017 Jul;17(4):386-392. doi: 10.1038/tpj.2016.34. Epub 2016 May 10.
6
Short Term Survival after Admission for Heart Failure in Sweden: Applying Multilevel Analyses of Discriminatory Accuracy to Evaluate Institutional Performance.瑞典心力衰竭入院后的短期生存率:应用歧视准确性的多层次分析来评估机构绩效。
PLoS One. 2016 Feb 3;11(2):e0148187. doi: 10.1371/journal.pone.0148187. eCollection 2016.
7
Applying measures of discriminatory accuracy to revisit traditional risk factors for being small for gestational age in Sweden: a national cross-sectional study.应用鉴别准确性指标重新审视瑞典小于胎龄儿的传统风险因素:一项全国性横断面研究。
BMJ Open. 2014 Jul 30;4(7):e005388. doi: 10.1136/bmjopen-2014-005388.
8
Genetic-based prediction of disease traits: prediction is very difficult, especially about the future.基于基因的疾病性状预测:预测非常困难,尤其是对未来的预测。
Front Genet. 2014 Jun 2;5:162. doi: 10.3389/fgene.2014.00162. eCollection 2014.
9
Predictive genetic testing for the identification of high-risk groups: a simulation study on the impact of predictive ability.预测性基因检测在高危人群识别中的应用:预测能力影响的模拟研究。
Genome Med. 2011 Jul 28;3(7):51. doi: 10.1186/gm267.
10
Discriminative accuracy of genomic profiling comparing multiplicative and additive risk models.基因组分析比较乘法风险模型和加法风险模型的判别准确性。
Eur J Hum Genet. 2011 Feb;19(2):180-5. doi: 10.1038/ejhg.2010.165. Epub 2010 Nov 17.

本文引用的文献

1
Genetic screening for hypersusceptibles in industry.工业中超敏人群的基因筛查。
Med Hypotheses. 1981 Mar;7(3):393-9. doi: 10.1016/0306-9877(81)90075-x.
2
Looking at genes in the workplace.
Science. 1982 Jul 23;217(4557):336-7. doi: 10.1126/science.7089567.
3
Predictive identification of hypersusceptible individuals.超敏感个体的预测性识别。
J Occup Med. 1982 May;24(5):369-74. doi: 10.1097/00043764-198205000-00007.
4
Genetic screening: implications for preventive medicine.基因筛查:对预防医学的影响。
Am J Public Health. 1983 Mar;73(3):243-5. doi: 10.2105/ajph.73.3.243.
5
Hypersusceptibility and genetic problems in occupational medicine--a consensus report.
J Occup Med. 1973 Jul;15(7):564-73.
6
Genetic screening.基因筛查
Annu Rev Genet. 1975;9:67-89. doi: 10.1146/annurev.ge.09.120175.000435.

危险因素筛查的流行病学评估:在基因筛查中的应用

Epidemiologic evaluation of screening for risk factors: application to genetic screening.

作者信息

Khoury M J, Newill C A, Chase G A

出版信息

Am J Public Health. 1985 Oct;75(10):1204-8. doi: 10.2105/ajph.75.10.1204.

DOI:10.2105/ajph.75.10.1204
PMID:3862352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1646387/
Abstract

To assess the usefulness of screening for risk factors, we derived arithmetic relationships between screening parameters (sensitivity, specificity, and positive predictive value PPV) and risk factor frequency, disease frequency and relative risk. We evaluated these relationships in the special case of genetic markers and disease susceptibility. It can be shown that even in the face of very large relative risks, sensitivity and positive predictive value are affected by the relative magnitude of disease and genetic marker frequencies. When the genetic marker is less frequent than the disease, PPV increases with increasing relative risk but sensitivity remains low. When the genetic marker is more frequent than the disease, sensitivity increases with increasing relative risk but PPV remains low. When marker and disease frequencies are equal, both PPV and sensitivity increase with increasing relative risks, but very high relative risks (greater than 100) have to be obtained for rare diseases. Depending on the goals of the screening program, these relationships can be used to predict the relative magnitudes of false positives (low PPV) and false negatives (low sensitivity). This approach can be generalized to evaluate nongenetic risk factors in screening programs as well.

摘要

为评估危险因素筛查的效用,我们推导了筛查参数(敏感性、特异性和阳性预测值PPV)与危险因素频率、疾病频率及相对风险之间的算术关系。我们在基因标记物与疾病易感性的特殊情况下评估了这些关系。结果表明,即使面对非常高的相对风险,敏感性和阳性预测值仍受疾病和基因标记物频率相对大小的影响。当基因标记物的频率低于疾病频率时,阳性预测值随相对风险的增加而升高,但敏感性仍然较低。当基因标记物的频率高于疾病频率时,敏感性随相对风险的增加而升高,但阳性预测值仍然较低。当标记物和疾病频率相等时,阳性预测值和敏感性均随相对风险的增加而升高,但对于罕见疾病而言,必须获得非常高的相对风险(大于100)。根据筛查项目的目标,这些关系可用于预测假阳性(低阳性预测值)和假阴性(低敏感性)的相对大小。这种方法也可推广用于评估筛查项目中的非遗传危险因素。